|
⚲
|
| Keyboard |
| Katz Barrett
✚
|
|
|---|---|
| CIK # | 0001841628 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001841628] | |
| 4 | [0001841628] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Miragen Therapeutics Inc | |
| Katz Barrett |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-02-08 | Grant | 108,000 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-17 | Option exercise | 24,853 | $23.03 | 572,365 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-01-17 | Option exercise | 24,853 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-17 | Sell | 24,853 | $37.21 | 924,780 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-13 | Option exercise | 4,147 | $23.03 | 95,505 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-13 | Sell | 4,147 | $37.01 | 153,480 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-01-13 | Option exercise | 4,147 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-01-10 | Option exercise | 47,377 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-10 | Sell | 47,377 | $35.30 | 1,672,408 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-10 | Option exercise | 47,377 | $23.03 | 1,091,092 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-01-09 | Option exercise | 12,623 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-09 | Option exercise | 12,623 | $23.03 | 290,708 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-01-09 | Sell | 12,623 | $33.04 | 417,064 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2022-02-02 | Grant | 110,000 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Employee Stock Option (right to buy) · derivative
|
2021-01-18 | Grant | 356,000 | $0.00 |